AVITA Medical, Inc.

RCEL

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001762303

SEC filings (opens in a new tab)

In the last 90 days, AVITA Medical, Inc. insiders filed 1 open-market purchase and 0 sales; 73 institutions reported holding it in 13F filings for Q2 2026, worth $20.4M in total; no superinvestor holds it.

Other share classesAVHHL

Q2 2022 vs. Q1 2022

How the institutions holding AVITA Medical, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of RCEL: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	68	3	56	−9
Shares	6.88M	82.6K	5.07M	−1.73M (−25.4%)
Value	$58.1M	$701.0K	$24.0M	−$33.4M (−58.1%)

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held AVITA Medical, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to RCEL in Q2 2022
Institution	Shares	Value	% of portfolio
Millennium Management LLC	267,163	$1.27M	0.00%
Ergoteles LLC	101,963	$484.0K	0.01%
Citadel Advisors LLC	87,139	$414.0K	0.00%
Two Sigma Investments, LP	58,110	$276.0K	0.00%
Cubist Systematic Strategies, LLC	29,711	$141.0K	0.00%
Qube Research & Technologies Ltd	22,053	$105.0K	0.00%
Jump Financial, LLC	21,000	$100.0K	0.00%
Squarepoint Ops LLC	13,279	$63.0K	0.00%
AQR Capital Management LLC	10,086	$48.0K	0.00%
Trust Co of Vermont	195	$1.00K	0.00%
Point72 Hong Kong Ltd	145	$1.00K	0.00%
Wagner Wealth Management, LLC	130	$1.00K	0.00%
Credit Suisse AG	13	$0	0.00%
PEAK6 Investments LLC	3,770	–	–

Sold out (23)

Institutions that held AVITA Medical, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of RCEL in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Artemis Investment Management LLP	91,022	$771.0K
Nuveen Asset Management, LLC	73,768	$571.0K
ETF Managers Group, LLC	35,065	$300.0K
Granahan Investment Management Inc	25,782	$219.0K
Allianz Asset Management GmbH	23,602	$200.0K
Rhumbline Advisers	22,913	$194.0K
JPMorgan Chase & Co	17,501	$149.0K
HRT Financial LP	15,991	$135.0K
Deutsche Bank AG	14,131	$120.0K
American International Group, Inc.	12,059	$102.0K
Engineers Gate Manager LP	11,846	$100.0K
Price T Rowe Associates Inc	11,290	$96.0K
Allspring Global Investments Holdings, LLC	11,279	$95.0K
Manufacturers Life Insurance Company, The	10,694	$90.7K
California State Teachers Retirement System	10,489	$89.0K
STRS Ohio	5,500	$46.0K
Amalgamated Bank	3,967	$34.0K
Legal & General Group Plc	2,616	$22.0K
Ameritas Investment Partners, Inc.	1,872	$16.0K
Nisa Investment Advisors, LLC	1,700	$14.0K
Captrust Financial Advisors	389	$3.00K
Steward Partners Investment Advisory, LLC	195	$2.00K
CFS Investment Advisory Services, LLC	12,423	$1.00K

Not filed for Q2 2022 yet (3)

Institutions that held AVITA Medical, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCEL in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Blackcrane Capital, LLC	43,324	$367.0K
Parametric Portfolio Associates LLC	35,334	$300.0K
Amalgamated Financial Corp.	3,967	$34.0K